DNA topoisomerase 1 facilitates the transcription and replication of the ebola virus genome

Journal of Virology

Volumn 87, Issue 16, 2013, Pages 8862-8869

  Takahashi, Kei ^a   Halfmann, Peter ^b   Oyama, Masaaki ^a   Kozuka Hata, Hiroko ^a   Noda, Takeshi ^a   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; EBOLA VIRUS PROTEIN L; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EBOLA VIRUS; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LIFE CYCLE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CELL LINE; DNA TOPOISOMERASES, TYPE I; EBOLAVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PROTEIN INTERACTION MAPPING; RNA REPLICASE; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84881257512     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03544-12     Document Type: Article

References (41)

1. Sanchez A, Geisbert TW, Feldmann H. 2007. Filoviridae: Marburg and Ebola viruses, p 1409-1448. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams % Wilkins, Philadelphia, PA.
2. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W. 2001. Vesicular release of Ebola virus matrix protein VP40. Virology 283:1-6.
3. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. 2002. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol. 76:4855-4865.
4. Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ. 2002. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:593-602.
5. Mühlberger E, Lötfering B, Klenk HD, Becker S. 1998. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J. Virol. 72:8756-8764.
6. Mühlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J. Virol. 73: 2333-2342.
7. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343.
8. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31:1947-1960.
9. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Jr, Chiorini J, Maury W. 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. U. S. A. 108:8426-8431.
10. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. 2006. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol. 80:10109-10116.
11. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
12. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178.
13. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:13871-13876.
14. Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 12:1313-1319.
15. Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN. 2003. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 77:1812-1819.
16. Iwasa A, Halfmann P, Noda T, Oyama M, Kozuka-Hata H, Watanabe S, Shimojima M, Watanabe T, Kawaoka Y. 2011. Contribution of Sec61α to the life cycle of Ebola virus. J. Infect. Dis. 204(Suppl 3):919-926.
17. Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y. 2004. Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics. J. Virol. 78:999-1005.
18. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20:87-90.
19. Gorai T, Goto H, Noda T, Watanabe T, Kozuka-Hata H, Oyama M, Takano R, Neumann G, Watanabe S, Kawaoka Y. 2012. F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc. Natl. Acad. Sci. U. S. A. 109: 4615-4620.
20. Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. 2008. Generation of biologically contained Ebola viruses. Proc. Natl. Acad. Sci. U. S. A. 105:1129-1133.
21. Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173:1-6.
22. Octaviani CP, Ozawa M, Yamada S, Goto H, Kawaoka Y. 2010. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J. Virol. 84:10918-10922.
23. Sekiguchi J, Shuman S. 1997. Site-specific ribonuclease activity of eukaryotic DNA topoisomerase 1. Mol. Cell 1:89-97.
24. Takahashi H, Sawa H, Hasegawa H, Sata T, Hall W, Kurata T. 2002. Binding and dissociation of human topoisomerase I with hairpin-loop RNAs: implications for the regulation of HIV-1 replication. Biochem. Biophys. Res. Commun. 297:593-599.
25. Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, Dolnik O, Basler CF, Becker S, Feldmann H. 2012. Inclusion bodies are a site of Ebola virus replication. J. Virol. 86:11779-11788.
26. Champoux JJ. 2001. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70:369-413.
27. Stewart L, Redinbo MR, Qiu X, Hol WG, Champoux JJ. 1998. A model for the mechanism of human topoisomerase 1. Science 279:1534-1541.
28. Kunimoto T, Nitta K, Tanaka T, Uehara N, Baba H, Takeuchi M, Yokokura T, Sawada S, Miyasaka T, Mutai M. 1987. Antitumor activity of 7-ethyl-10[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res. 47:5944-5947.
29. Svejstrup JQ, Christiansen K, Gromova II, Andersen AH, Westergaard O. 1991. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. J. Mol. Biol. 222:669-678.
30. Simmons DT, Melendy T, Usher D, Stillman B. 1996. Simian virus 40 large T antigen binds to topoisomerase 1. Virology 222:365-374.
31. Trowbridge PW, Roy R, Simmons DT. 1999. Human topoisomerase I promotes initiation of simian virus 40 DNA replication in vitro. Mol. Cell. Biol. 19:1686-1694.
32. Khopde S, Simmons DT. 2008. Simian virus 40 DNA replication is dependent on an interaction between topoisomerase 1 and the C-terminal end of T antigen. J. Virol. 82:1136-1145.
33. Yamada Y, Yamamoto N, Maeno K, Nishiyama Y. 1990. Role of DNA topoisomerase I in the replication of herpes simplex virus type 2. Arch. Virol. 110:121-127.
34. Takahashi H, Matsuda M, Kojima A, Sata T, Andoh T, Kurata T, Nagashima K, Hall WW. 1995. Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. Proc. Natl. Acad. Sci. U. S. A. 92:5694-5698.
35. Jardine D, Tachedjian G, Locarnini S, Birch C. 1993. Cellular topoisomerase I activity associated with HIV-1. AIDS Res. Hum. Retroviruses 9:1245-1250.
36. Weis JH, Fras AJ. 1981. DNA topoisomerase activity associated with Rous sarcoma virus. Virology 114:563-566.
37. Takahashi H, Sawa H, Hasegawa H, Shoya Y, Sata T, Hall WW, Nagashima K, Kurata T. 2002. Topoisomerase I and ATP activate cDNA synthesis of human immunodeficiency virus type 1. Biochem. Biophys. Res. Commun. 294:509-517.
38. Mühlberger E, Trommer S, Funke C, Volchkov V, Klenk HD, Becker S. 1996. Termini of all mRNA species of Marburg virus: sequence and secondary structure. Virology 223:376-380.
39. Weik M, Modrof J, Klenk HD, Becker S, Mühlberger E. 2002. Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J. Virol. 17:8532-8539.
40. Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. 2011. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J. Infect. Dis. 204:911-918.
41. Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, Hoenen T, Feldmann H. 2009. The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res. 140:8-14.